Bayer has revealed new data from FIDELITY, a pooled analysis from the phase 3 trials FIDELIO-DKD and FIGARO-DKD of Kerendia (Ingredient: finerenone), showing the drug's potential to have positive effects on mortality in patients with chronic kidney disease and type 2 diabetes (T2D).The FIDELITY tria
AstraZeneca’s Forxiga has once again demonstrated the substance’s effect on reducing cardiovascular events in patients with more than 40 percent ejection fraction, diluting the value of ejection fraction in the treatment of heart failure.Ejection fraction measures the amount of blood the heart's lef
You might think that foreign medical doctors may not easily choose to work in Korea, but Italian-born Paola Russo, who now leads a function within the pharmacovigilance group at Samsung Bioepis, seems to be an exception.“Sharing a living dream with Samsung Bioepis, I joined wholeheartedly with great
Some people and organizations are better at turning crises into opportunities than others. Myongji Hospital in Goyang, a bed town north of Seoul, is one of them, cementing its position amid the Covid-19 pandemic with swift and well-prepared responses to the public health crisis.It is now offering th
“I was particularly impressed about the company’s mission to save lives. I believe it is more fulfilling to work in the medical field to save other people, like doctors.”So said Joseph Witanto, 27, an assistant manager in Medical IP’s research and development (R&D) division, in a recent interview wi
Korea’s bio-industry is experiencing rapid growth, and the medical AI industry is no exception.Few other companies illustrate this trend better than medical AI startup VUNO. Since its founding in 2014, the company has quickly transformed into an international name.However, despite Korea’s increasing
The VIBac 2022, a two-day conference and exhibition, kicked off at the COEX in southern Seoul on Monday, featuring Korean and foreign businesses related to the fields of virus and bacteria.Visitors to the event can access technologies in various areas, including diagnostics, biopharmaceuticals, micr
Last Tuesday, a U.S. FDA expert committee recommended including the Omicron BA.4 and BA.5 subvariants in the Covid-19 booster shot in autumn. However, it quickly added that lengthy clinical trials could hinder the vaccines’ timely distribution, necessitating emerging technologies like computer simul
The Yonsei University College of Medicine (YUCM)’s Institute of Tropical Medicine hosted the 45th Tropical Medicine Symposium as an online meeting on Saturday to discuss ways to respond to various infectious diseases.Six infectious disease experts gave lectures to about 50 participants on global hea
Chinese pharmaceutical companies, including Antengene, Everest Medicines, and BeiGene, established Korean offshoots recently. Unlike other Chinese companies that used to export drug ingredients to Korea, these companies aim to target the Korean market with innovative drugs for serious diseases like
The suicide of professor Koh won-jung at Samsung Medical Center, an authority in tuberculosis and non-tuberculous mycobacteria (NTM), sent a great shock to the medical community in 2019.In the same year, another doctor killed himself. He was a thoracic surgeon treating patients for nearly 19 years a
The loss of routines in the lives of Korean people caused by Covid-19 appeared to have affected their physical states by, for instance, growing a muffin top.According to the "2017-2021 Nutrient Deficiency and Obesity Statistics" released by the Health Insurance Review and Assessment Service on April
COPENHAGEN – With the 2022 European Alliance of Associations for Rheumatology (EULAR) Congress holding an in-person conference for the first time in two years, Korean professors also had the chance to show off their recent research in the field.Notably, Professor Jung Jae-hyun of the Department of R
COPENHAGEN – Bristol Myers Squibb’s deucravacitinib, a lupus treatment candidate, drew keen attention from global rheumatologists as the company unveiled the phase 2 study at the 2022 European Alliance of Associations for Rheumatology (EULAR) Congress Saturday.The phase 2 PAISLEY study evaluated deu
COPENHAGEN -- Celltrion aims to gain the upper hand in the fiercely competitive infliximab biosimilar market through direct selling Remsima SC, a top manager said Thursday."Currently, competition for infliximab biosimilars is cut-throat," Celltrion Vice President Choi Byoung-seo said during an inter
COPENHAGEN -- A new analysis of the phase 3 clinical trial showed that Remsima SC (Ingredient: infliximab) made a significantly greater improvement in clinical outcomes compared to the intravenous (IV) in patients with rheumatoid arthritis (RA).The post-hoc study focused on confirming whether the nu
COPENHAGEN – The 2022 European Alliance of Associations for Rheumatology (EULAR 2022) European Congress of Rheumatology kicked off its 75th Scientific Assembly and Annual Meeting in Copenhagen, Denmark, on Wednesday.After two years of an online-only event due to the Covid-19 pandemic, EULAR has deci
COPENHAGEN -- The 2022 European Alliance of Associations for Rheumatology (EULAR 2022) European Congress of Rheumatology kicked off its four day-run on Wednesday.Many multinational pharmaceutical companies, including Celltrion of Korea, joined the convention, setting up booths to introduce the lates
After becoming the general manager of Merck Biopharma Korea in 2019, Javed Alam has worked to transform the company into a specialty care leader by responding to unmet needs in the area of rare diseases.Industry insiders say that despite the huge obstacle of the Covid-19 pandemic, Alam played a cent
There are more than 7,000 types of rare diseases in the world, according to the World Health Organization.In Korea, a rare disease is defined as a disease that affects fewer than 20,000 people or whose number of carriers is unknown because to diagnose a disease.The number of Korean patients with rar